Ocella®,Yasmin®, and/or Yaz®

Kane Legal is reviewing the following injuries caused by Ocella®,Yasmin®, and/or Yaz®:

• Blood Clot
• Stroke
• Cancer
• Death

If you or a loved one has taken Ocella, Yasmin, and/or Yaz, and has experienced a blood clot, stroke, cancer, and/or death, please call Kane Legal.

Ocella, Yasmin, and Yaz (ethinyl estradiol and drosperinone) are oral contraceptives.  They are manufactured by Bayer Healthcare.  Ocella and Yasmin are clone drugs.  They are identical, however, Ocella is the generic version.  They are prescribed for oral contraception.  Yaz is prescribed for mild acne treatment, oral contraception, and premenstrual dysmorphic disorder (PMDD).  Yasmin was approved by the Food and Drug Administration (F.D.A.) on May 11, 2001.  Yaz was approved by the F.D.A. on March 16, 2006.

The F.D.A. issued warning letters to Bayer, citing the company for misleading television and web site advertisements. The FDA said the ads misleadingly broadened the drug’s indications, overstated the products efficacy, and minimized serious risks associated with use of the drug.  In addition, several lawsuits filed against Bayer Healthcare have implicated these medications in the following side effects:

• Slight increase in the frequency of breast cancer
• Hyperkalemia (high potassium levels)-May cause heart rhythm abnormalities.
• Increased triglycerides
• Retinal vascular thrombosis
• Increased risk of thromboembolism
• Increased risk of gallbladder disease

If you or a loved one has been affected by one of these oral contraceptives, you may be entitled to compensation.  For a free legal consultation, please contact Kane Legal.